|
depression |
48 |
|
covid-19 |
32 |
|
youth mental health |
32 |
|
mental health |
28 |
|
post-traumatic stress disorder |
21 |
|
social unrest |
20 |
|
network analysis |
19 |
|
epidemiology |
17 |
|
population-based |
17 |
|
rumination |
17 |
|
loneliness |
16 |
|
anxiety |
15 |
|
experience sampling method |
14 |
|
adolescents |
13 |
|
stress |
13 |
|
validation study |
13 |
|
bipolar disorder |
12 |
|
momentary positive affect |
12 |
|
mortality |
12 |
|
schizophrenia |
12 |
|
pattern glare |
11 |
|
perceptual distortions |
11 |
|
young people |
11 |
|
youth |
11 |
|
affect |
10 |
|
antidepressants |
10 |
|
diabetes complications |
10 |
|
diabetes mellitus |
10 |
|
mental disorders |
10 |
|
meta-analysis |
10 |
|
momentary assessment |
10 |
|
psychotic disorders |
10 |
|
temporal trends |
10 |
|
adolescent |
9 |
|
autism spectrum disorder |
9 |
|
autistic disorder |
9 |
|
epidemiological youth |
9 |
|
esm |
9 |
|
excess life-years lost |
9 |
|
ideas of reference |
9 |
|
life events |
9 |
|
life expectancy |
9 |
|
negative symptoms |
9 |
|
premature mortality |
9 |
|
psychotic-like experiences |
9 |
|
schizotypal personality disorder |
9 |
|
social context |
9 |
|
systematic review |
9 |
|
traumatic events |
9 |
|
young adult |
9 |
|
children & adolescents |
8 |
|
dementia |
8 |
|
depressive symptoms |
8 |
|
dose-dependent effect |
8 |
|
epidemiological study |
8 |
|
hallucination |
8 |
|
latent class analysis |
8 |
|
mass screening |
8 |
|
memory |
8 |
|
pandemic |
8 |
|
persistent psychotic experience |
8 |
|
pharmacoepidemiology |
8 |
|
ptsd symptoms |
8 |
|
suicide |
8 |
|
trauma exposure |
8 |
|
amotivation |
7 |
|
avolition |
7 |
|
coping strategies |
7 |
|
correlates |
7 |
|
digitalization |
7 |
|
electronic health record |
7 |
|
euclidean distance analysis |
7 |
|
first-episode psychosis |
7 |
|
functional outcome |
7 |
|
identity |
7 |
|
latent class growth analysis |
7 |
|
lithium |
7 |
|
longitudinal course |
7 |
|
personal attributes |
7 |
|
post-complication mortality |
7 |
|
pre-existing mental disorders |
7 |
|
pregnancy |
7 |
|
prospective follow-up |
7 |
|
psychiatric patients |
7 |
|
psychiatric symptomatology |
7 |
|
psychopathology |
7 |
|
real-world functioning |
7 |
|
self |
7 |
|
self-differentiation |
7 |
|
smartphone addiction |
7 |
|
social support |
7 |
|
suicidal ideation |
7 |
|
survey |
7 |
|
adults |
6 |
|
affective psychoses |
6 |
|
aged |
6 |
|
anxiety disorders |
6 |
|
asian continental ancestry group |
6 |
|
communityolder |
6 |
|
coping styles |
6 |
|
environmental stressors |
6 |
|
family functioning |
6 |
|
growth mixture modeling |
6 |
|
health surveys |
6 |
|
interview, psychological |
6 |
|
lifetime prevalence |
6 |
|
major depressive episode |
6 |
|
mental disorders / epidemiology |
6 |
|
population surveys |
6 |
|
prevalence |
6 |
|
risk factors |
6 |
|
self-reported cognitive complaints |
6 |
|
stressful life events |
6 |
|
suicidal behaviours |
6 |
|
suicide-related rumination |
6 |
|
transcranial direct current stimulation |
6 |
|
traumatic stress symptoms |
6 |
|
accident prevention |
5 |
|
accidental falls |
5 |
|
adult mental disorders |
5 |
|
anhedonia |
5 |
|
childhood environment |
5 |
|
childhood neglect |
5 |
|
cognitive disorders |
5 |
|
exercise |
5 |
|
housing |
5 |
|
mood stabilizers |
5 |
|
sibling-comparison |
5 |
|
years of potential life lost |
5 |
|
acute coronary syndrome |
4 |
|
antipsychotics |
4 |
|
benzodiazepines |
4 |
|
cardioprotective medications |
4 |
|
chronic kidney disease |
4 |
|
clozapine |
4 |
|
congenital malformations |
4 |
|
delivery complications |
4 |
|
early detection |
4 |
|
gaze perception |
4 |
|
health service utilization |
4 |
|
late-life depression |
4 |
|
long-acting injectables |
4 |
|
mentalisation |
4 |
|
neonatal outcomes |
4 |
|
obstetric complications |
4 |
|
prenatal exposure |
4 |
|
prescribing trends |
4 |
|
prescription patters |
4 |
|
revascularization |
4 |
|
risk prediction model |
4 |
|
second-generation antipsychotics |
4 |
|
social cognition |
4 |
|
treatment inequality |
4 |
|
z-drugs |
4 |
|
antipsychotic |
3 |
|
cardiac heart defects |
3 |
|
children |
3 |
|
chronotype |
3 |
|
circadian rhythms |
3 |
|
clinical trial |
3 |
|
cognitive dysfunction |
3 |
|
cognitive impairment |
3 |
|
complication burden |
3 |
|
diabetes |
3 |
|
discontinuation |
3 |
|
electronic health record database |
3 |
|
episodic |
3 |
|
ischemic stroke |
3 |
|
learning |
3 |
|
life years lost |
3 |
|
living environment |
3 |
|
mindfulness |
3 |
|
mortality gap |
3 |
|
mortality trend |
3 |
|
mortalityschizophrenia |
3 |
|
neighbourhood |
3 |
|
non-affective psychoses |
3 |
|
pharmaco-epidemiology |
3 |
|
population-based study |
3 |
|
psychological distress |
3 |
|
reward |
3 |
|
sleep |
3 |
|
stroke |
3 |
|
tdcs feasibility study |
3 |
|
teratogenicity |
3 |
|
transcranial direct current stimulation (tdcs) |
3 |
|
transcranial magnetic stimulation |
3 |
|
treatment |
3 |
|
validation |
3 |
|
youth depression |
3 |
|
asociality |
2 |
|
brain stimulation |
2 |
|
caregivers |
2 |
|
early psychosis |
2 |
|
ecological momentary assessment |
2 |
|
environmental stress |
2 |
|
experience sampling |
2 |
|
functioning |
2 |
|
home-based exercise |
2 |
|
mental health - environmental aspects - china - hong kong |
2 |
|
mental health - social aspects - china - hong kong |
2 |
|
mental illness |
2 |
|
neighborhood |
2 |
|
old age |
2 |
|
post-stroke mortality |
2 |
|
randomised controlled trial |
2 |
|
self-stigma |
2 |
|
stigma |
2 |
|
stigma coping |
2 |
|
stroke risk |
2 |
|
tai chi |
2 |
|
urban environment |
2 |
|
ypll |
2 |
|
chronic medical illness |
1 |
|
cognitive function |
1 |
|
geriatric assessment |
1 |
|
later life |
1 |
|
neuropsychological tests |
1 |
|
parental care |
1 |
|
parental control |
1 |
|
parent–child relationships |
1 |
|
peer social support |
1 |
|
personality tests |
1 |
|
psychiatric status rating scales |
1 |
|
romantic relational aggression |
1 |
